IBDEI05B ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6838,1,4,0)
 ;;=4^940.3
 ;;^UTILITY(U,$J,358.3,6838,2)
 ;;=^275515
 ;;^UTILITY(U,$J,358.3,6839,0)
 ;;=940.4^^51^454^19
 ;;^UTILITY(U,$J,358.3,6839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6839,1,3,0)
 ;;=3^Cornea/Conj,Oth Burn
 ;;^UTILITY(U,$J,358.3,6839,1,4,0)
 ;;=4^940.4
 ;;^UTILITY(U,$J,358.3,6839,2)
 ;;=^275516
 ;;^UTILITY(U,$J,358.3,6840,0)
 ;;=941.12^^51^454^31
 ;;^UTILITY(U,$J,358.3,6840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6840,1,3,0)
 ;;=3^Eye Erythema
 ;;^UTILITY(U,$J,358.3,6840,1,4,0)
 ;;=4^941.12
 ;;^UTILITY(U,$J,358.3,6840,2)
 ;;=^275531
 ;;^UTILITY(U,$J,358.3,6841,0)
 ;;=977.8^^51^454^4
 ;;^UTILITY(U,$J,358.3,6841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6841,1,3,0)
 ;;=3^Allergy to Fluorescein
 ;;^UTILITY(U,$J,358.3,6841,1,4,0)
 ;;=4^977.8
 ;;^UTILITY(U,$J,358.3,6841,2)
 ;;=^276154
 ;;^UTILITY(U,$J,358.3,6842,0)
 ;;=989.83^^51^454^110
 ;;^UTILITY(U,$J,358.3,6842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6842,1,3,0)
 ;;=3^Toxic Effect of Silicone
 ;;^UTILITY(U,$J,358.3,6842,1,4,0)
 ;;=4^989.83
 ;;^UTILITY(U,$J,358.3,6842,2)
 ;;=^303356
 ;;^UTILITY(U,$J,358.3,6843,0)
 ;;=995.29^^51^454^3
 ;;^UTILITY(U,$J,358.3,6843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6843,1,3,0)
 ;;=3^Adverse Effect of Drug
 ;;^UTILITY(U,$J,358.3,6843,1,4,0)
 ;;=4^995.29
 ;;^UTILITY(U,$J,358.3,6843,2)
 ;;=^334181
 ;;^UTILITY(U,$J,358.3,6844,0)
 ;;=998.30^^51^454^25
 ;;^UTILITY(U,$J,358.3,6844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6844,1,3,0)
 ;;=3^Disruption OP Wound
 ;;^UTILITY(U,$J,358.3,6844,1,4,0)
 ;;=4^998.30
 ;;^UTILITY(U,$J,358.3,6844,2)
 ;;=^336767
 ;;^UTILITY(U,$J,358.3,6845,0)
 ;;=998.31^^51^454^27
 ;;^UTILITY(U,$J,358.3,6845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6845,1,3,0)
 ;;=3^Disruption of Internal OP Wound
 ;;^UTILITY(U,$J,358.3,6845,1,4,0)
 ;;=4^998.31
 ;;^UTILITY(U,$J,358.3,6845,2)
 ;;=^336843
 ;;^UTILITY(U,$J,358.3,6846,0)
 ;;=998.32^^51^454^26
 ;;^UTILITY(U,$J,358.3,6846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6846,1,3,0)
 ;;=3^Disruption of External OP Wound
 ;;^UTILITY(U,$J,358.3,6846,1,4,0)
 ;;=4^998.32
 ;;^UTILITY(U,$J,358.3,6846,2)
 ;;=^336844
 ;;^UTILITY(U,$J,358.3,6847,0)
 ;;=804.00^^51^454^37
 ;;^UTILITY(U,$J,358.3,6847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6847,1,3,0)
 ;;=3^FX Skull/Face Mult w/o Intracranial Inj
 ;;^UTILITY(U,$J,358.3,6847,1,4,0)
 ;;=4^804.00
 ;;^UTILITY(U,$J,358.3,6847,2)
 ;;=^273780
 ;;^UTILITY(U,$J,358.3,6848,0)
 ;;=V10.84^^51^454^47
 ;;^UTILITY(U,$J,358.3,6848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6848,1,3,0)
 ;;=3^Hx Eye CA,Personal
 ;;^UTILITY(U,$J,358.3,6848,1,4,0)
 ;;=4^V10.84
 ;;^UTILITY(U,$J,358.3,6848,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,6849,0)
 ;;=V16.9^^51^454^46
 ;;^UTILITY(U,$J,358.3,6849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6849,1,3,0)
 ;;=3^Hx CA,Family
 ;;^UTILITY(U,$J,358.3,6849,1,4,0)
 ;;=4^V16.9
 ;;^UTILITY(U,$J,358.3,6849,2)
 ;;=^295301
 ;;^UTILITY(U,$J,358.3,6850,0)
 ;;=V19.0^^51^454^45
 ;;^UTILITY(U,$J,358.3,6850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6850,1,3,0)
 ;;=3^Hx Blindness/Visual Loss,Family
 ;;^UTILITY(U,$J,358.3,6850,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,6850,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,6851,0)
 ;;=V60.0^^51^454^55
 ;;^UTILITY(U,$J,358.3,6851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6851,1,3,0)
 ;;=3^Lack of Housing
 ;;^UTILITY(U,$J,358.3,6851,1,4,0)
 ;;=4^V60.0
 ;;^UTILITY(U,$J,358.3,6851,2)
 ;;=^295539
 ;;^UTILITY(U,$J,358.3,6852,0)
 ;;=V65.5^^51^454^13
 ;;^UTILITY(U,$J,358.3,6852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6852,1,3,0)
 ;;=3^Condition Not Found
 ;;^UTILITY(U,$J,358.3,6852,1,4,0)
 ;;=4^V65.5
 ;;^UTILITY(U,$J,358.3,6852,2)
 ;;=^295564
 ;;^UTILITY(U,$J,358.3,6853,0)
 ;;=V67.51^^51^454^12
 ;;^UTILITY(U,$J,358.3,6853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6853,1,3,0)
 ;;=3^Completed Trmt of High Risk Med
 ;;^UTILITY(U,$J,358.3,6853,1,4,0)
 ;;=4^V67.51
 ;;^UTILITY(U,$J,358.3,6853,2)
 ;;=^295577
 ;;^UTILITY(U,$J,358.3,6854,0)
 ;;=V87.39^^51^454^15
 ;;^UTILITY(U,$J,358.3,6854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6854,1,3,0)
 ;;=3^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,6854,1,4,0)
 ;;=4^V87.39
 ;;^UTILITY(U,$J,358.3,6854,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,6855,0)
 ;;=365.11^^51^455^20
 ;;^UTILITY(U,$J,358.3,6855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6855,1,3,0)
 ;;=3^Glaucoma,Open Angle
 ;;^UTILITY(U,$J,358.3,6855,1,4,0)
 ;;=4^365.11
 ;;^UTILITY(U,$J,358.3,6855,2)
 ;;=Open Angle Glaucoma^51203
 ;;^UTILITY(U,$J,358.3,6856,0)
 ;;=365.12^^51^455^16
 ;;^UTILITY(U,$J,358.3,6856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6856,1,3,0)
 ;;=3^Glaucoma,Low Tension
 ;;^UTILITY(U,$J,358.3,6856,1,4,0)
 ;;=4^365.12
 ;;^UTILITY(U,$J,358.3,6856,2)
 ;;=Low Tension Glaucoma^265223
 ;;^UTILITY(U,$J,358.3,6857,0)
 ;;=365.63^^51^455^19
 ;;^UTILITY(U,$J,358.3,6857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6857,1,3,0)
 ;;=3^Glaucoma,Neovascular
 ;;^UTILITY(U,$J,358.3,6857,1,4,0)
 ;;=4^365.63
 ;;^UTILITY(U,$J,358.3,6857,2)
 ;;=Neovascular Glaucoma^268778
 ;;^UTILITY(U,$J,358.3,6858,0)
 ;;=365.10^^51^455^22
 ;;^UTILITY(U,$J,358.3,6858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6858,1,3,0)
 ;;=3^Glaucoma,Open Angle Unspec
 ;;^UTILITY(U,$J,358.3,6858,1,4,0)
 ;;=4^365.10
 ;;^UTILITY(U,$J,358.3,6858,2)
 ;;=^51206
 ;;^UTILITY(U,$J,358.3,6859,0)
 ;;=365.13^^51^455^25
 ;;^UTILITY(U,$J,358.3,6859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6859,1,3,0)
 ;;=3^Glaucoma,Pigmentary
 ;;^UTILITY(U,$J,358.3,6859,1,4,0)
 ;;=4^365.13
 ;;^UTILITY(U,$J,358.3,6859,2)
 ;;=Pigmentary Glaucoma^51211
 ;;^UTILITY(U,$J,358.3,6860,0)
 ;;=365.20^^51^455^26
 ;;^UTILITY(U,$J,358.3,6860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6860,1,3,0)
 ;;=3^Glaucoma,Prim Angle Closure
 ;;^UTILITY(U,$J,358.3,6860,1,4,0)
 ;;=4^365.20
 ;;^UTILITY(U,$J,358.3,6860,2)
 ;;=^51195
 ;;^UTILITY(U,$J,358.3,6861,0)
 ;;=365.52^^51^455^27
 ;;^UTILITY(U,$J,358.3,6861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6861,1,3,0)
 ;;=3^Glaucoma,Pseudoexfoliation
 ;;^UTILITY(U,$J,358.3,6861,1,4,0)
 ;;=4^365.52
 ;;^UTILITY(U,$J,358.3,6861,2)
 ;;=Pseudoexfoliation Glaucoma^268771
 ;;^UTILITY(U,$J,358.3,6862,0)
 ;;=365.15^^51^455^29
 ;;^UTILITY(U,$J,358.3,6862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6862,1,3,0)
 ;;=3^Glaucoma,Residual Open Angle
 ;;^UTILITY(U,$J,358.3,6862,1,4,0)
 ;;=4^365.15
 ;;^UTILITY(U,$J,358.3,6862,2)
 ;;=Residual Open Angle Glaucoma^268751
 ;;^UTILITY(U,$J,358.3,6863,0)
 ;;=365.31^^51^455^32
 ;;^UTILITY(U,$J,358.3,6863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6863,1,3,0)
 ;;=3^Glaucoma,Steroid Induced
 ;;^UTILITY(U,$J,358.3,6863,1,4,0)
 ;;=4^365.31
 ;;^UTILITY(U,$J,358.3,6863,2)
 ;;=Steroid Induced Glaucoma^268761
 ;;^UTILITY(U,$J,358.3,6864,0)
 ;;=365.61^^51^455^11
 ;;^UTILITY(U,$J,358.3,6864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6864,1,3,0)
 ;;=3^Glaucoma W/Pupillary Block
 ;;^UTILITY(U,$J,358.3,6864,1,4,0)
 ;;=4^365.61
 ;;^UTILITY(U,$J,358.3,6864,2)
 ;;=Glaucoma W/Pupillary Block^268776
 ;;^UTILITY(U,$J,358.3,6865,0)
 ;;=365.23^^51^455^13
 ;;^UTILITY(U,$J,358.3,6865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6865,1,3,0)
 ;;=3^Glaucoma,Chr Angle Closure
 ;;^UTILITY(U,$J,358.3,6865,1,4,0)
 ;;=4^365.23
 ;;^UTILITY(U,$J,358.3,6865,2)
 ;;=^268756
 ;;^UTILITY(U,$J,358.3,6866,0)
 ;;=363.71^^51^455^43
 ;;^UTILITY(U,$J,358.3,6866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6866,1,3,0)
 ;;=3^Serous Choroidal Detachment
 ;;^UTILITY(U,$J,358.3,6866,1,4,0)
 ;;=4^363.71
 ;;^UTILITY(U,$J,358.3,6866,2)
 ;;=Choroidal Detachment^268699
 ;;^UTILITY(U,$J,358.3,6867,0)
 ;;=365.51^^51^455^24
 ;;^UTILITY(U,$J,358.3,6867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6867,1,3,0)
 ;;=3^Glaucoma,Phacolytic
 ;;^UTILITY(U,$J,358.3,6867,1,4,0)
 ;;=4^365.51
 ;;^UTILITY(U,$J,358.3,6867,2)
 ;;=Phacolytic Glaucoma^265226
 ;;^UTILITY(U,$J,358.3,6868,0)
 ;;=365.01^^51^455^21
 ;;^UTILITY(U,$J,358.3,6868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6868,1,3,0)
 ;;=3^Glaucoma,Open Angle Suspect
 ;;^UTILITY(U,$J,358.3,6868,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,6868,2)
 ;;=Open Angle Glaucoma Suspect^268747
 ;;^UTILITY(U,$J,358.3,6869,0)
 ;;=365.04^^51^455^37
 ;;^UTILITY(U,$J,358.3,6869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6869,1,3,0)
 ;;=3^Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,6869,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,6869,2)
 ;;=Ocular Hypertension^85124
 ;;^UTILITY(U,$J,358.3,6870,0)
 ;;=365.03^^51^455^44
 ;;^UTILITY(U,$J,358.3,6870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6870,1,3,0)
 ;;=3^Steroid Responder
 ;;^UTILITY(U,$J,358.3,6870,1,4,0)
 ;;=4^365.03
 ;;^UTILITY(U,$J,358.3,6870,2)
 ;;=^268749
 ;;^UTILITY(U,$J,358.3,6871,0)
 ;;=366.11^^51^455^41
 ;;^UTILITY(U,$J,358.3,6871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6871,1,3,0)
 ;;=3^Pseudoexfoliation w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,6871,1,4,0)
 ;;=4^366.11
 ;;^UTILITY(U,$J,358.3,6871,2)
 ;;=^265538
 ;;^UTILITY(U,$J,358.3,6872,0)
 ;;=365.02^^51^455^1
 ;;^UTILITY(U,$J,358.3,6872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6872,1,3,0)
 ;;=3^Anatomic Narrow Angle
 ;;^UTILITY(U,$J,358.3,6872,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,6872,2)
 ;;=Anatomic Narrow Angle^268748
 ;;^UTILITY(U,$J,358.3,6873,0)
 ;;=364.53^^51^455^39
 ;;^UTILITY(U,$J,358.3,6873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6873,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,6873,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,6873,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,6874,0)
 ;;=364.42^^51^455^42
 ;;^UTILITY(U,$J,358.3,6874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6874,1,3,0)
 ;;=3^Rubeosis Iridis w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,6874,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,6874,2)
 ;;=Rubeosis Iridis w/o Glaucoma^268716
 ;;^UTILITY(U,$J,358.3,6875,0)
 ;;=364.77^^51^455^2
